ATLAS Biolabs
ATLAS Biolabs is a leading European service provider specializing in molecular genetic analyses, diagnostics, and complex bioinformatics data analyses. They offer a wide range of services including next-generation sequencing, microarray analyses, digital karyotyping, mutation analyses, and more, serving research institutions, clinics, pharmaceutical and biotech companies, and medical professionals. Their mission is to provide high-quality, reliable, and flexible genetic testing and analysis services to support scientific research and personalized medicine.
Industries
Nr. of Employees
small (1-50)
ATLAS Biolabs
Berlin, Berlin, Germany
Products
Molekulargenetische Analysen
Genomische, klinische und bioinformatische Dienstleistungen wie Next-Generation-Sequencing, genomweite Expressions- und SNP-Analysen, digitale Karyotypisierungen und komplexe Mutationsanalysen.
OncoScan FFPE Assay Kit Analysis
Analysis of FFPE material DNA using the OncoScan FFPE assay kit to achieve high resolution of more than 900 cancer genes and somatic mutations.
Digital molecular karyotyping
Laboratory service for identifying the causes of genetic diseases using digital karyotyping, copy number variations (CNV), amplifications, deletions, and loss of heterozygosity (LOH) with high-resolution oligonucleotide microarrays.
Onkogen-Analysen
Analysis of DNA from FFPE material using the OncoScan-FFPE-Assay-Kit for high-resolution analysis of cancer genes, somatic mutations, and copy-number variations.
SEER Proteograph XT
Mass spectrometry-based protein analysis providing high-resolution biomarker identification at the peptide level on state-of-the-art Bruker timsTOF HT mass spectrometers.
Olink Explore
Antibody-based protein biomarker analysis carried out in a certified Olink laboratory using NGS-based multiplex analysis for 384 up to 5,400 proteins.
Molekulargenetische Analysen
Genomische, klinische und bioinformatische Dienstleistungen wie Next-Generation-Sequencing, genomweite Expressions- und SNP-Analysen, digitale Karyotypisierungen und komplexe Mutationsanalysen.
OncoScan FFPE Assay Kit Analysis
Analysis of FFPE material DNA using the OncoScan FFPE assay kit to achieve high resolution of more than 900 cancer genes and somatic mutations.
Digital molecular karyotyping
Laboratory service for identifying the causes of genetic diseases using digital karyotyping, copy number variations (CNV), amplifications, deletions, and loss of heterozygosity (LOH) with high-resolution oligonucleotide microarrays.
Onkogen-Analysen
Analysis of DNA from FFPE material using the OncoScan-FFPE-Assay-Kit for high-resolution analysis of cancer genes, somatic mutations, and copy-number variations.
SEER Proteograph XT
Mass spectrometry-based protein analysis providing high-resolution biomarker identification at the peptide level on state-of-the-art Bruker timsTOF HT mass spectrometers.
Olink Explore
Antibody-based protein biomarker analysis carried out in a certified Olink laboratory using NGS-based multiplex analysis for 384 up to 5,400 proteins.
Services
Analysis pipelines and delivery of processed NGS data for WGS, WES and RNA-seq projects including QC, alignment, variant calling and annotation.
Normalization and statistical analysis of microarray datasets with QC graphics, annotated tables and publication-ready reports.
RNA sequencing and microarray-based transcriptome analyses including exon-level and isoform detection, differential expression and gene fusion detection.
High-resolution microarray-based cytogenetic analyses for detection of CNVs, LOH and chromosomal aberrations with delivery of original data and QC reports.
Analysis of FFPE-derived DNA for cancer gene profiling, somatic mutation detection and genome-wide CNV/LOH analysis with lists of putative aberrations and quality reports.
Genome-wide and pharmacogenetic genotyping services for ADME-relevant markers with genotype export in common formats for downstream analysis.
Analysis pipelines and delivery of processed NGS data for WGS, WES and RNA-seq projects including QC, alignment, variant calling and annotation.
Normalization and statistical analysis of microarray datasets with QC graphics, annotated tables and publication-ready reports.
RNA sequencing and microarray-based transcriptome analyses including exon-level and isoform detection, differential expression and gene fusion detection.
High-resolution microarray-based cytogenetic analyses for detection of CNVs, LOH and chromosomal aberrations with delivery of original data and QC reports.
Analysis of FFPE-derived DNA for cancer gene profiling, somatic mutation detection and genome-wide CNV/LOH analysis with lists of putative aberrations and quality reports.
Genome-wide and pharmacogenetic genotyping services for ADME-relevant markers with genotype export in common formats for downstream analysis.
Expertise Areas
- NGS data analysis
- Transcriptomics and exon-level expression analysis
- Microarray data analysis and statistical reporting
- Genotyping and pharmacogenetics
Key Technologies
- Whole-genome sequencing (WGS)
- Whole-exome sequencing (WES)
- RNA sequencing (RNA-seq)
- ChIP sequencing (ChIP-seq)
News & Updates
A study investigating the role of genetic factors in the course of SARS-CoV-2 infection, focusing on membrane proteins ACE2 and TMPRSS2, funded by the German Federal Ministry of Education and Research.
A publication evaluating HPV DNA as biomarkers for recurrent CIN2/3 post-treatment.
A study on risk prediction using genetic and clinical parameters.
A comprehensive study on genetic causes of hereditary nonsyndromic hearing loss.
A study investigating the role of genetic factors in the course of SARS-CoV-2 infection, focusing on membrane proteins ACE2 and TMPRSS2, funded by the German Federal Ministry of Education and Research.
A publication evaluating HPV DNA as biomarkers for recurrent CIN2/3 post-treatment.
A study on risk prediction using genetic and clinical parameters.
A comprehensive study on genetic causes of hereditary nonsyndromic hearing loss.